Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Flammaspray** is a topical spray formulation designed for soothing sunburn and minor skin irritations on the face and body, suitable for infants, children, and adults. Its active ingredient is **oxaceprol** (also referred to as hydroxyproline in some sources), which provides anti-inflammatory and soothing effects through inhibition of pro-inflammatory mediators. The product is fragrance-free, paraben-free, and propellant gas-free, delivering a translucent milky mist that forms a protective layer on the skin. Marketed primarily in Europe, it is available over-the-counter and distributed through companies like Sinclair Pharma and Alliance Pharmaceuticals.[1][3][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Flammaspray.